Literature DB >> 22584059

BRCT domains: A little more than kin, and less than kind.

Dietlind L Gerloff1, Nicholas T Woods, April A Farago, Alvaro N A Monteiro.   

Abstract

BRCT domains are versatile protein modular domains found as single units or as multiple copies in more than 20 different proteins in the human genome. Interestingly, most BRCT-containing proteins function in the same biological process, the DNA damage response network, but show specificity in their molecular interactions. BRCT domains have been found to bind a wide array of ligands from proteins, phosphorylated linear motifs, and DNA. Here we discuss the biology of BRCT domains and how a domain-centric analysis can aid in the understanding of signal transduction events in the DNA damage response network.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584059      PMCID: PMC3413754          DOI: 10.1016/j.febslet.2012.05.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  76 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Assembly of cell regulatory systems through protein interaction domains.

Authors:  Tony Pawson; Piers Nash
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

3.  Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

Authors:  Maria Rodriguez; Xiaochun Yu; Junjie Chen; Zhou Songyang
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

4.  Multiple sequence alignment using ClustalW and ClustalX.

Authors:  Julie D Thompson; Toby J Gibson; Des G Higgins
Journal:  Curr Protoc Bioinformatics       Date:  2002-08

5.  The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors.

Authors:  K Hofmann; P Bucher
Journal:  Trends Biochem Sci       Date:  1995-09       Impact factor: 13.807

Review 6.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

7.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks.

Authors:  Arkady Celeste; Oscar Fernandez-Capetillo; Michael J Kruhlak; Duane R Pilch; David W Staudt; Alicia Lee; Robert F Bonner; William M Bonner; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

8.  Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.

Authors:  Julie A Clapperton; Isaac A Manke; Drew M Lowery; Timmy Ho; Lesley F Haire; Michael B Yaffe; Stephen J Smerdon
Journal:  Nat Struct Mol Biol       Date:  2004-05-09       Impact factor: 15.369

9.  OMA 2011: orthology inference among 1000 complete genomes.

Authors:  Adrian M Altenhoff; Adrian Schneider; Gaston H Gonnet; Christophe Dessimoz
Journal:  Nucleic Acids Res       Date:  2010-11-27       Impact factor: 16.971

10.  Selecton 2007: advanced models for detecting positive and purifying selection using a Bayesian inference approach.

Authors:  Adi Stern; Adi Doron-Faigenboim; Elana Erez; Eric Martz; Eran Bacharach; Tal Pupko
Journal:  Nucleic Acids Res       Date:  2007-06-22       Impact factor: 16.971

View more
  18 in total

1.  Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.

Authors:  Verline Justilien; Kayla C Lewis; Kayleah M Meneses; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.

Authors:  Hua Wang; Dongxi Xiang; Ben Liu; Aina He; Helena J Randle; Kelvin Xi Zhang; Anushka Dongre; Norman Sachs; Allison P Clark; Luwei Tao; Qing Chen; Vladimir V Botchkarev; Ying Xie; Ning Dai; Hans Clevers; Zhe Li; David M Livingston
Journal:  Cell       Date:  2019-06-27       Impact factor: 41.582

3.  Direct Binding to Replication Protein A (RPA)-coated Single-stranded DNA Allows Recruitment of the ATR Activator TopBP1 to Sites of DNA Damage.

Authors:  Julyana Acevedo; Shan Yan; W Matthew Michael
Journal:  J Biol Chem       Date:  2016-04-26       Impact factor: 5.157

Review 4.  The Rtt107 BRCT scaffold and its partner modification enzymes collaborate to promote replication.

Authors:  Lisa Hang; Xiaolan Zhao
Journal:  Nucleus       Date:  2016-07-06       Impact factor: 4.197

Review 5.  Multi-BRCT scaffolds use distinct strategies to support genome maintenance.

Authors:  Bingbing Wan; Lisa E Hang; Xiaolan Zhao
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

6.  Biochemical analysis of TOPBP1 oligomerization.

Authors:  Ahhyun Kim; Katrina Montales; Kenna Ruis; Holly Senebandith; Hovik Gasparyan; Quinn Cowan; W Matthew Michael
Journal:  DNA Repair (Amst)       Date:  2020-09-21

Review 7.  Incorporating computational resources in a cancer research program.

Authors:  Nicholas T Woods; Ankita Jhuraney; Alvaro N A Monteiro
Journal:  Hum Genet       Date:  2014-10-17       Impact factor: 4.132

8.  BRCT-domain protein BRIT1 influences class switch recombination.

Authors:  Wei-Feng Yen; Ashutosh Chaudhry; Bharat Vaidyanathan; William T Yewdell; Joseph N Pucella; Rahul Sharma; Yulong Liang; Kaiyi Li; Alexander Y Rudensky; Jayanta Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-19       Impact factor: 11.205

Review 9.  Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease.

Authors:  D R Cook; K L Rossman; C J Der
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

10.  SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.

Authors:  Shannon P Fortin Ensign; Alison Roos; Ian T Mathews; Harshil D Dhruv; Serdar Tuncali; Jann N Sarkaria; Marc H Symons; Joseph C Loftus; Michael E Berens; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2016-01-13       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.